Skip to main content

Advertisement

SpringerLink
Log in

Factors associated with long-term survival in central nervous system metastases

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Background

Cancer is a leading cause of death worldwide; central nervous system metastases (CNSm) are amongst the most common complications of cancer and are associated with high morbidity and mortality. The aim of the study was to associate clinic and oncologic characteristics with the possibility of survival for ≥ 1 year.

Materials and methods

A prospective cohort in two referral centers recollected clinical and oncologic data from patients diagnosed with CNSm. Chronic metastases were defined as those patients that survived for ≥ 12 months after the diagnosis of CNSm.

Results

Of 613 patients with CNSm, 554 had solid tumors as the primary cancer and were included; 405 (73%) were women, the most common primary cancer site were breast, lung and urologic. Chronic CNSm were found in 260 (47%) and were compared to those who did not. After multivariate logistic regression analysis, variables associated with good prognosis (living > 12 months) were: female sex (HR 0.55), single CNSm (HR 0.39), diagnosis of CNSm during initial extension studies or during presentation of cancer (HR 0.43), and occipital location (HR 0.62).

Conclusions

Long-term survival in patients with CNSm remains a topic of debate; their bad prognosis could be changing towards improvement. Clinical findings are typically overlooked in CNSm reports and prognostic scales. After our findings, we propose to include them in forthcoming studies to aid prognostic considerations. Factors associated with prolonged survival found in our study include female gender, timing of CNSm diagnosis, occipital lobe location, and single CNSm.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J cancer 136:E359–E386. https://doi.org/10.1002/ijc.29210

    Article  CAS  PubMed  Google Scholar 

  2. Nayak L, Lee EQ, Wen PY (2012) Epidemiology of brain metastases. Curr Oncol Rep 14:48–54. https://doi.org/10.1007/s11912-011-0203-y

    Article  Google Scholar 

  3. Ostrom QT, Wright CH, Barnholtz-Sloan JS (2018) Brain metastases: epidemiology, 1st edn. Elsevier, New York

    Google Scholar 

  4. Goldberg SB, Contessa JN, Omay SB, Chiang V (2015) Lung cancer brain metastases. Cancer J 21:398–403. https://doi.org/10.1097/PPO.0000000000000146

    Article  PubMed  Google Scholar 

  5. Lombardi G, Di Stefano AL, Farina P et al (2014) Systemic treatments for brain metastases from breast cancer, non-small cell lung cancer, melanoma and renal cell carcinoma: an overview of the literature. Cancer Treat Rev 40:951–959. https://doi.org/10.1016/j.ctrv.2014.05.007

    Article  PubMed  Google Scholar 

  6. Di Lorenzo R, Ahluwalia MS (2017) Targeted therapy of brain metastases: latest evidence and clinical implications. Ther Adv Med Oncol 9:781–796

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Cooper JB, Ronecker JS, Tobias ME et al (2018) Molecular sequence of events and signaling pathways in cerebral metastases. Anticancer Res 38:1859–1877. https://doi.org/10.21873/anticanres.12424

    Article  CAS  PubMed  Google Scholar 

  8. Chamberlain MC, Baik CS, Gadi VK et al (2017) Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma. Neuro Oncol 19:1–24. https://doi.org/10.1093/neuonc/now197

    Article  CAS  Google Scholar 

  9. Fernandes AW, Wu B, Turner RM (2017) Brain metastases in non-small cell lung cancer patients on epidermal growth factor receptor tyrosine kinase inhibitors: symptom and economic burden. J Med Econ 20:1136–1147. https://doi.org/10.1080/13696998.2017.1361960

    Article  PubMed  Google Scholar 

  10. Pelletier EM, Shim B, Goodman S, Amonkar MM (2008) Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis. Breast Cancer Res Treat 108:297–305. https://doi.org/10.1007/s10549-007-9601-0

    Article  PubMed  Google Scholar 

  11. Gaspar L, Scott C, Rotman M et al (1997) Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (rtog) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745–751

    Article  CAS  PubMed  Google Scholar 

  12. Sperduto PW, Kased N, Roberge D et al (2011) Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 30:419–425. https://doi.org/10.1200/JCO.2011.38.0527

    Article  PubMed  PubMed Central  Google Scholar 

  13. Barnholtz-Sloan JS, Yu C, Sloan AE et al (2012) A nomogram for individualized estimation of survival among patients with brain metastasis. Neuro Oncol 14:910–918. https://doi.org/10.1093/neuonc/nos087

    Article  PubMed  PubMed Central  Google Scholar 

  14. Venur VA, Ahluwalia MS (2015) Prognostic scores for brain metastasis patients: use in clinical practice and trial design. Chin Clin Oncol. https://doi.org/10.21037/CCO.V4I2.6689

    Article  PubMed  Google Scholar 

  15. Tsukada Y, Fouad A, Pickren JW, Lane WW (1983) Central nervous system metastasis from breast carcinoma. Autopsy study. Cancer 52:2349–2354

    Article  CAS  PubMed  Google Scholar 

  16. Platta CS, Khuntia D, Mehta MP, Suh JH (2010) Current treatment strategies for brain metastasis and complications from therapeutic techniques. Am J Clin Oncol 33:398–407. https://doi.org/10.1097/COC.0b013e318194f744

    Article  PubMed  Google Scholar 

  17. Kotecha R, Vogel S, Suh JH et al (2016) A cure is possible: a study of 10-year survivors of brain metastases. J Neurooncol 129:545–555. https://doi.org/10.1007/s11060-016-2208-8

    Article  PubMed  Google Scholar 

  18. Lutterbach J, Bartelt S, Ostertag C (2002) Long-term survival in patients with brain metastases. J Cancer Res Clin Oncol 128:417–425. https://doi.org/10.1007/s00432-002-0354-1

    Article  PubMed  Google Scholar 

  19. Chao ST, Barnett GH, Liu SW et al (2006) Five-year survivors of brain metastases: a single-institution report of 32 patients. Int J Radiat Oncol 66:801–809. https://doi.org/10.1016/j.ijrobp.2006.05.015

    Article  Google Scholar 

  20. Hall WA, Djalilian HR, Nussbaum ES, Cho KH (2000) Long-term survival with metastatic cancer to the brain. Med Oncol 17:279–286

    Article  CAS  PubMed  Google Scholar 

  21. Takeshima H, Kuratsu J-I, Nishi T, Ushio Y (2002) Prognostic factors in patients who survived more than 10 years after undergoing surgery for metastatic brain tumors: report of 5 cases and review of the literature. Surg Neurol 58(2):118–123

    Article  Google Scholar 

  22. Thiagarajan A, Yamada Y (2017) Radiobiology and radiotherapy of brain metastases. Clin Exp Metastasis 34:411–419. https://doi.org/10.1007/s10585-017-9865-7

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neuro-oncology Unit, Instituto Nacional de Cancerología, Av. San Fernando 22 Col Sección XVI, ZC 14050, Mexico City, México

    Bernardo Cacho-Díaz & Héctor Spínola-Maroño

  2. Neuro-oncology Unit, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico

    Alberto González-Aguilar

  3. Thoracic Oncology Unit, Instituto Nacional de Cancerología, Mexico City, Mexico

    Oscar Arrieta

Authors
  1. Bernardo Cacho-Díaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Héctor Spínola-Maroño
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alberto González-Aguilar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Oscar Arrieta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bernardo Cacho-Díaz.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cacho-Díaz, B., Spínola-Maroño, H., González-Aguilar, A. et al. Factors associated with long-term survival in central nervous system metastases. J Neurooncol 140, 159–164 (2018). https://doi.org/10.1007/s11060-018-2946-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-018-2946-x

Keywords

Search

Navigation